1. Home
  2. BCAX vs CASS Comparison

BCAX vs CASS Comparison

Compare BCAX & CASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • CASS
  • Stock Information
  • Founded
  • BCAX 2018
  • CASS 1906
  • Country
  • BCAX United States
  • CASS United States
  • Employees
  • BCAX N/A
  • CASS N/A
  • Industry
  • BCAX
  • CASS Business Services
  • Sector
  • BCAX
  • CASS Consumer Discretionary
  • Exchange
  • BCAX NYSE
  • CASS Nasdaq
  • Market Cap
  • BCAX 733.5M
  • CASS 588.1M
  • IPO Year
  • BCAX 2024
  • CASS 1996
  • Fundamental
  • Price
  • BCAX $13.00
  • CASS $43.18
  • Analyst Decision
  • BCAX Strong Buy
  • CASS Buy
  • Analyst Count
  • BCAX 6
  • CASS 1
  • Target Price
  • BCAX $39.50
  • CASS $45.00
  • AVG Volume (30 Days)
  • BCAX 327.7K
  • CASS 45.7K
  • Earning Date
  • BCAX 03-04-2025
  • CASS 04-17-2025
  • Dividend Yield
  • BCAX N/A
  • CASS 2.87%
  • EPS Growth
  • BCAX N/A
  • CASS N/A
  • EPS
  • BCAX N/A
  • CASS 1.39
  • Revenue
  • BCAX N/A
  • CASS $219,894,000.00
  • Revenue This Year
  • BCAX N/A
  • CASS N/A
  • Revenue Next Year
  • BCAX N/A
  • CASS $7.70
  • P/E Ratio
  • BCAX N/A
  • CASS $31.06
  • Revenue Growth
  • BCAX N/A
  • CASS 3.13
  • 52 Week Low
  • BCAX $11.10
  • CASS $37.99
  • 52 Week High
  • BCAX $28.09
  • CASS $49.16
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • CASS 51.44
  • Support Level
  • BCAX N/A
  • CASS $42.30
  • Resistance Level
  • BCAX N/A
  • CASS $45.45
  • Average True Range (ATR)
  • BCAX 0.00
  • CASS 1.10
  • MACD
  • BCAX 0.00
  • CASS 0.08
  • Stochastic Oscillator
  • BCAX 0.00
  • CASS 55.84

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment.

Share on Social Networks: